Sensei Biotherapeutics Q1 EPS $(0.42) Up From $(4.00) YoY
Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(0.42) per share. This is a 89.5 percent increase over losses of $(4.00) per share from the same period last year.
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 10)